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Abstract

Ewing's Sarcoma is a pediatric bone cancer that is highly aggressive, leading to a five year
survival rate of only 30% even with multi-modal treatment protocols. Improved therapeutic
options are desperately needed. Our research has focused on the ability of the nonpsychoactive cannabinoid, ajulemic acid, to induce apoptosis and decrease metastatic
potential in cells from members of the Ewing Sarcoma family of tumors. Recently, we
explored the effects of the naturally-occurring cannabinoid, cannabidiol, on threedimensional spheroids that mimic the cellular components and microenvironment of Ewing's
tumors. We looked at how this treatment affects VEGF, a mediator of angiogenesis, to
determine if these cannabinoids work through similar cellular pathways. Data with
cannabidiol can then be compared to data collected from ajulemic acid studies to determine if
these cannabinoids work through similar cellular pathways.
Ewing's Sarcoma

"Ewing's Bone Sarcoma is a malignant childhood bone and soft tissue tumor known to be
highly aggressive and invasive" (Sanceau, Truchet, and Bauvois, 2003). This cancer starts in
the bones and spreads quickly to the soft tissues and often the lungs, making it extremely
dangerous. People with Ewing's may feel pain, sometimes notice a mass, or a bone may
fracture, but these symptoms usually go unnoticed until the cancer has already spread,
making the disease even more dangerous. Because of the nature of the disease to spread
before being noticed, the survival rates for Ewing's are considerably low. Children who are
diagnosed after the disease has spread have less than a 30% survival rate. Teens typically
have a survival rate of about 56%. Ewing's is commonly treated with chemotherapy,

radiation, and many times surgery to remove the mass. In many cases, amputation may be
necessary. Alternative treatment plans are clearly needed considering the low survival rate
even with treatment.
Cannabinoids are a class of compounds found in the Cannabis, or marijuana, plant
that has been shown to have medicinal value. Over the past six years, students on our
research team have been able to perform research using ajulemic acid, which is a synthetic,
non-psychoactive compound structurally similar to those found in the Cannabis plant.
ajulemic acid is shown to kill tumor cells, block angiogenesis, and decrease tumor cell
invasiveness (Recht et al., 2001). These factors all contribute to metastasis, which is the
ability for cancer to spread from its primary site to other parts of the body. Because the
debate over the legalization of using marijuana for medicinal purposes is growing, we wanted
to compare the effects of ajulemic acid with the effects of the naturally occurring compound,
cannabidiol (CBD).
Cannabidiol is a naturally-occurring compound derived from the Cannabis plant.
Many people may be concerned with using a substance coming directly from the marijuana
plant. However, CBD is a non-psychoactive constituent of marijuana extract with a lowtoxicity profile. Studies have shown that cannabinoids can have a wide array of effects on the
immune, digestive, reproductive, ocular, cardiovascular, and central nervous system (Kogan,
2005). It has also been shown that CBD can inhibit breast cancer cell proliferation and
invasion, as well as Lewis lung carcinoma growth (McAllister et al., 2010). The mechanisms
by which it effects the various body systems are beginning to be researched, and the
mechanisms vary. Studies suggest cannabinoids' anti-angiogenic effect may be linked to their

ability to modulate the response of cells to growth factors, such as VEGF. Cannabinoids can
interfere with these growth factors, blocking growth factor-dependent cancers from spreading
(Kogan, 2005). VEGF, vascular endothelial growth factor, is central in angiogenesis of
cancer cells as it aids in the recruitment of a blood supply to tumors. Blocking angiogenesis
is necessary to inhibit metastasis because it is the means by which a tumor receives blood
supply to feed the tumor. If blood vessels are not within close proximity to the tumor, the
tumor cannot survive (Huang eta!., 2003). Inhibition ofVEGF production has been reported
in tumor cells treated with CBD. For these reasons, our research is focusing on how CBD
effects VEGF in spheroid models of Ewing's Sarcoma. We hypothesized that VEGF levels
would decrease when exposed to CBD.
Two-dimensional cell cultures have led to many discoveries in understanding human
tissues and diseases, but this type of cell culture does have limitations. In 2D cell cultures,
there is limited cell-cell and cell-matrix contacts and a lack of realistic mass transfer
gradients (Katz, 2013). Recently, systems have been developed to grow three-dimensional
cultures in vitro that would mimic the microenvironment of the cancer in vivo. It is
hypothesized that tumor cell biology and treatment response would be more accurate and
informative if done in a setting that is similar to the tumor's microenvironment in order to
observe the intra/intercellular interactions (Upreti et al., 2011 ). Because of the greater
accuracy, our research has turned to three-dimensional configurations. Spheroids were made
containing components that would be found in a tumor setting in the body in order to observe
the interactions. These spheroids were made in round-bottom well plates that encourage the
cells to cling to one another but not adhere to the bottom of the plate. This model reflects the

suspended nature of a clump of tumor cells in the body. The spheroids contained three cell
lines: endothelial cells, which aid in the formation of new blood vessels so the tumor can
survive, fibroblasts, which serve as the structural framework holding the tumor cells together,
and the cancer cell line, which was taken from a Ewing's sarcoma tumor that had
metastasized to the lung. These cell lines together best resemble tumor conditions in the body
that we can treat and analyze in vitro.
Materials and Methods
Cell Lines and 3D Tumor Spheroid Models

A standard spheroids protocol was utilized to create the spheroid models that would be used
to grow and test the Ewing's Sarcoma tumors. In an ultra low-binding, round bottom well
plate, three cell lines were plated: EPC endothelial cells, WI-38 fibroblasts, and TC71-PM4GR, the Ewing's Sarcoma cancer cell line. Twenty-four of the 96 wells were plated with onethousand cells per well. The cells in each cell line were counted, and the volume needed was
then calculated. The cells were resuspended in 50 mL of mixed media and gently mixed.
50~L were

added to each well, then the well plates were placed in a 37° incubator. After

being in the incubator for three days,
cells to continue to grow. On day six,

50~L

of fresh mixed media was added to encourage the

lOO~L

of Opti-MEM (low serum) was added. On day

eight, treatment of cannabidiol was administered. Six well plates were left untreated, six were
treated with 1O~M. six were treated with

20~M,

and six were treated with 32~M of

cannabidiol. Samples were taken for an enzyme-linked immunosorbent assay (ELISA) at 18
hours, because it is shown that at 24-48 hours, CBD induces the cancer cells to die. We took
samples before the 24-48 hour time period to see only the drugs effects on the VEGF levels.

ELISA
The DuoSet ELISA Development System kit and protocol were used on the cell lines. The
samples were taken 18 hours after being treated with cannabidiol. The ELISA test measured
the amount ofVEGF present in the growth media of the spheroids. After performing the
protocol for the ELISA test, the optical density of each well plate was determined using a
microplate reader. Absorbance values were used to determine the VEGF levels in each well
plate and to analyze the effects of various concentrations of CBD on the VEGF levels.
Results

Through this research phase, we wanted to determine how CBD affected the metastatic
potential of Ewing's Sarcoma tumor cells, specifically through the VEGF mechanism.
Studies with other cancer cell lines involved demonstrated the ability of CBD to inhibit
VEGF production. For this reason, we expected to see VEGF levels decrease as the
concentration of CBD increased. The study looked at untreated cell lines and cells treated
with 10!-!M, 20!-!M, and 32!-!M of cannabidiol. The following graphs show the results from
the ELISA tests, with they-axis showing the VEGF level present after treatment, and the xaxis showing the concentration of CBD administered.
Referring to Figure 1, the first trial produced unexpected results. In Figure 1A, we
found a dependence on VEGF levels to CBD concentrations, but in the opposite way
expected: VEGF levels increased as CBD concentration increased. We expected inhibition of
VEGF production, but instead saw more VEGF. One can also see that there was less than 100
pg/mL difference in VEGF levels for the untreated and

10~-tM

concentrations ofCBD. In

Figure lB, the same trend was found, with the difference being in the drop ofVEGF levels at

B

Figure 1. CBD eoncentratiDns effect on VEGF levels. In both A and B tllere is ~~g trend. in VOOF

levels.as CBD concentrations increase.

After obtaining unexpected results, we ran the test again using the same cell lines to
ensure that we did not make a systematic or random error. The results from Trial 2 are shown
in Figure 2.
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Figure ~- Results ftom Trial2. In both A and B there is an increasing 1:J:eM in VEGF levels as CBD
concentrations increase.

With the second set of data, we again found an increase in VEGF levels as CBD
concentrations increased. There was again less than 100 pg/mL difference in the VEGF level
between the untreated and 10!-!M concentration. In both Figures 2A and 2B, the most
significant increase in VEGF levels was between the 10!-!M and 20!-!M concentrations of
CBD. There was less than 100 pg/mL difference in the VEGF levels between the
32~-tM

20~-tM

and

concentrations of CBD.
Again not getting the results that were expected, and after seeing inconsistencies, we

decided to run the test on entirely new aliquots of cell lines. We ran the test on the old and
new cell lines again for comparison sake. Figure 3 represents the old cell lines in Trial 3, and
Figure 4 represents the new cell lines in Trial 3.
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Figure 3. Resu.lts ftom Trial3 using old cell lines.

With the old cell lines run once more in Trial3, there was a leveling off ofVEGF levels as
concentrations increased. CBD did not appear to have an effect on VEGF levels.

We hypothesized that completely starting new cell lines would result in an inhibition of
VEGF production as CBD levels increased, but the result in Trial 3 with new cell lines did
not produce support that hypothesis. In Figure 4A, results were different. There was a
decrease instead of increase in VEGF levels at 20~-tM of CBD. In Figure 4B, we saw much
the same as before: little change from untreated to
20~-tM.

10~-tM

and a spike in VEGF levels at

We again saw a decrease in VEGF levels at 32!-!M like we did in Figure lB.
The data from all three trials were not incredibly consistent. In some trials, we saw an

increase in VEGF levels as the concentration of Cannabidiol increased, and in others there
was little change at all. These results suggest that Cannabidiol does not effect VEGF levels in
a consistent manner in Ewing's Sarcoma tumor cells.

Significance
Our results showed that cannabidiol does not have an effect on VEGF levels. There are
multiple pathways and mechanisms through which metastasis of cancer cells is achieved, and
metastasis is a highly complicated process depending on multiple interactions (Sanceau,
Truchet, and Bauvois, 2003). This study only looked at the VEGF mechanism. Cannabidiol
has been shown in other studies to inhibit metastasis. Since each type of cancer is different, it
is probable that CBD can have an inhibitory effect on Ewing's Sarcoma cells, just through a
different mechanism than the one we studied. Because of this, further research is
recommended on other possible mechanisms effecting metastasis. MMP-2 mediates another
mechanism that induces invasion and migration, much like MMP-9 (a mechanism
concurrently tested with similar results to VEGF and CBD). Our research team plans to test
CBD's effect on MMP-2levels through the same procedures discussed earlier. It is important
that we not only demonstrate that CBD can inhibit Ewing's Sarcoma's spread, but also the
mechanism that it effects. Other future research plans include working with a computer
program called Oncomine. This program gathers clinical data from a wide variety of sources.
Through these additional measures, we will seek to identify which proteins are causing the
rapid spread of Ewing's Sarcoma and work backwards. Similar tests could then be run on
these proteins to understand cannabidiol's effect on it.
While researching the effects of cannabidiol on Ewing's Sarcoma, we have also been
studying the effects of the synthetic compound AJA. We hypothesize that AJA and CBD will
inhibit Ewing's Sarcoma through the same mechanisms. Research will continue to determine
the similarities and differences between the naturally occurring and synthetic form. A better

understanding of how these drugs compare can provide the public with a better background
ofknowledge when debating and voting on the issue ofthe legalization of medicinal
manJuana.

Psycho-Oncology
Ewing's Sarcoma, and pediatric cancers in general, can put a great strain on familiesparticularly the cancer patients, parents, and their siblings. From diagnosis to treatment, each
step in the life of cancer patients and their families can be extremely stressful and
emotionally devastating. Because of these negative psychological effects, specialized
intervention plans should be implemented for the patient and each family member. To
understand how to best manage these psychological issues, we will look at the main
problems concerning patients, parents, and families, and the coping methods that are shown
to be most effective.
Patients, parents, and siblings of pediatric cancers all face different psychological
issues because of their role and responsibilities within the family unit. It has been shown in
studies that the diagnosis and treatment of pediatric cancer is a stressful and emotionally
taxing event for the patient. Survival rates are improving for some types of pediatric cancers;
however the "course of treatment for childhood cancer, such as chemotherapy, surgery or
radiotherapy, is still a very stressful experience in the life of a child" (Li et al., 201 0). In a
study examining physical, emotional, and psycho-social well-being in cancer patients from
Hong Kong, a higher than normal level of anxiety, sadness, and worry was shown in the
patients. Over half of these patients were also at risk for depression (Li et al., 201 0). Even the
patients who survive are at risk for post-traumatic stress disorder (PTSD). "Nearly 20% to
35% of childhood cancer survivors meet diagnostic criteria for PTSD," which is more than
double the rate for the general population (Stoppelbein, Greening, and Wells, 2013). More
than 50% of pediatric cancer survivors show subclinical post-traumatic stress symptoms

(PTSS). Risk factors for developing PTSD or PTSS "include older age, being female, being
on treatment, shorter length of time since treatment ended, anxiety, parents' higher level of
PTSS, and parents' perceiving treatment as intense" (Stoppelbein, Greening, and Wells,
2013). With the increased stress level, emotional instability, risk for depression and PTSD,
interventions need to be made to improve patients' quality of life.
In order to create the most effective intervention plan for pediatric cancer patients,
health-care professionals must understand what coping is and what coping strategies are used
by these children. "Coping is a process involving cognitive and behavioral attempts to meet
the demands of, and to control the emotions generated by, the situation" (Li et al., 2010).
There are two types of coping strategies that children may use either on their own or in
conjunction during a stressful event: problem-focused and emotion-focused. According to
Lazarus and Folkman, problem-focused coping includes "seeking social support, planful
problem solving, and confronting. Emotion-focused coping includes "positive reappraisal,
self-control, escape-avoidance, accepting responsibility, and distancing" (Li et a!., 201 0).
Based on many studies, it is often culturally based as to which coping strategy the child uses
more frequently. In Western children, problem-focused coping was found most commonly,
specifically seeking social support. In Eastern children, emotion-focused was most common,
specifically through self-control. It seems that emotion-focused coping is used most often
when it seems like nothing can be done to change the situation. There is also variance in
coping strategies used by different age groups. Younger children rarely use confronting,
positive reappraisal and accepting of responsibility as a coping method. Evidence suggests
that as "children become older their locus of control shifts from an external to an internal

control" (Li et al., 201 0). Results from this study on coping mechanisms demonstrate the
importance of targeting interventions based on culture, age, developmental stage, and coping
strategy to reduce emotional stress. For example, those patients who use problem-focused
coping in efforts to reduce the impact of the problem encountered, it would be best to use
interventions that include providing detailed information about procedures that will be used
along with instructions that enhance problem-solving activities. For patients that use
emotion-focused coping, interventions that focus on regulating emotions by relaxation,
distraction, or denial, would be most effective. By understanding how the child is
approaching their diagnosis and treatment, more effective interventions can be created.
Another promising approach to supportive care for pediatric cancer patients, is
massage therapy. "Massage Therapy as a Supportive Care Intervention for Children with
Cancer" reviews literature on massage therapy "to inform healthcare providers about the
potential uses of massage for children with cancer" (Hughes et al. , 2008). Massage therapy
has been used to "alleviate stress and muscle cramping, induce relaxation, improve
circulation and lymph flow, promote muscle tone, increase range of motion, and encourage
recovery from injuries and medical procedures" (Hughes et al., 2008). There are a number of
physiological benefits from massage therapy. Parents of patients have reported the use of
massage to help counteract toxicities from chemotherapy and radiation therapy, including
fatigue and nausea. This article cites studies that have shown that massage therapy can lead
to decreased heart rate, blood pressure, and respiratory rate. Massage therapy also appears to
manage symptoms associated with cancer treatment such as nausea, mood, appetite,
insomnia, pain, mobility, fatigue, bowel movement patterns, concentration, and appearance.

Massage therapy can also provide psychological benefits. "Overall quality of life measures
improved significantly" for patients receiving massage therapy compared to a control group.
There was a decrease in anxiety and depression. With the reduction of stress provided by the
massage therapy, immune function benefits are also seen. Boosting the immune system can
be highly beneficial during periods of profound immune suppression. "Massage therapy may
suppress the activity of the hypothalamic-pituitary-adrenal axis, causing decreases in cortisol
and neuropeptide levels" (Hughes et al., 2008). This may improve immune function by
increasing natural killer cell number and activity. For pediatric patients, massage therapy can
be extremely beneficial to improve both physiological and psychological symptoms
associated with cancer treatment.
Although the patient is suffering great physical and emotional pain, the parents are
dealing with emotional instability and a number of new responsibilities and stressors. It is
important to understand the parents' perspective and ways to manage their psychological
issues, because the parents emotional state can impact the rest of the family and the patient
both mentally and physically. When a parents' child is diagnosed with cancer, parents have
been shown to exhibit "higher emotional distress levels and more psychosomatic complaints
than norm populations" (Hoekstra-Weebers et al., 2012). They are suddenly bombarded with
frequent hospital visits and the responsibility of managing their child's healthcare. Not only
are the time demands and responsibilities difficult for parents to adjust to, they are also
having to see their child suffer through intense treatment regimens and constant
hospitalization (Gage, 2013). Because of these issues associated with parents of pediatric
cancer patients, interventions are needed to help parents cope.

There are a number of ways for parents to cope with the diagnosis and treatment of
their child's cancer such as social support groups and psycho-education programs. A study
was conducted by the Department of Community Health and Behavior at the University of
Buffalo to examine the mechanics of effective social support. They specifically looked at
how people ask for, manage, and perceive offers of social support. To better understand the
dynamics of social support, researchers interviewed parents about their child's diagnosis,
their experience with social support, and how they managed their various responsibilities.
The following are the responses from parents. They often felt like they received many offers
of help immediately after diagnosis, however these quickly declined and they did not seem
genuine. Parents felt unsure of how to manage all of these offers, because they felt awkward
asking for help in what they really needed such as specific daily chores. For many families,
they were able to ask close family friends and family to help with these everyday tasks. It
was important for there to be a close relationship before the diagnosis, in order for the
parents to feel as if they could ask for help. These close relationships were able to help in
many daily tasks and help rally support from those that were not as close to the family. The
study found that less personal support, such as financial support, was easiest for parents to
accept from socially distant network members. This study provided important information
about how the parents view social support and the issues associated with it. Because of the
results from these studies, "it may be fruitful to design programs that counsel parents to
identify their needs and identify potential support providers with these distinctions in
mind" (Gage, 2013). With programs in place, parents can better receive support throughout
the treatment process and to fit their actual needs.

Studies have also been done to examine the effectiveness of structured psychoeducational programs (PeP) for parents of children with cancer. Their main goals in the PeP
was to "improve parents' knowledge on childhood cancer, increase parents' psychological
awareness and acceptance to diagnosis, recommend effective coping strategies, and decrease
their levels of anxiety and stress symptoms" (Othman et al., 201 0). Results showed that this
type of program enhanced parents' knowledge on childhood cancer and there was a trend
towards reduced anxiety. However, no statistical difference was found on measures of the
other goals in the study. Based on these results, the PeP can be used to increase knowledge
and reduce anxiety, but other coping strategies should be implemented to address the other
Issues.
Finally it should be noted that coping strategies vary amongst genders. For example,
mothers used social support more than fathers. Therefore, "when designing interventions for
parents, differences between the effects coping has on fathers' and mothers' psychological
functioning should be taken into account" (Hoekstra-Weebers et al., 2012). It is important
that parents find ways to cope and manage the stresses associated with pediatric cancer in
order to increase their quality of life and their families. Studies have shown that parental
stress, overprotection, and perceived child vulnerability, can cause negative effects on patient
adjustment and quality of life (Hullmann eta/., 2010).
There is one more important component of the immediate family that can be greatly
impacted by a pediatric cancer diagnosis and treatment. Those are the siblings of patients.
They have been referred to as "the forgotten ones," because they are often thought about the
least during their brother or sister's illness (Madan-Swain et al., 1993). During this time,

there are many added stressors to the sibling's daily life that can impact them in a negative
way and cause behavioral problems. These stressors include: "loss of parental attention ... ,
changes in family structure, roles, and expectations; concerns about the cause of their
sibling's illness; feelings of guilt, anxiety and shame; social avoidance; and avoidance of
affectual disclosure within the family," (Madan-Swain et al., 1993). These stressors have led
to internal and external psychological problems in many children, such as anxiety and
depression, problems in school, lower quality of life, and post-traumatic stress (Prchal and
Landolt, 2009). These results show that interventions need to be accessible for siblings of
pediatric cancer patients.
Studies have been conducted to evaluate the effectiveness of group therapy
intervention programs. In a study conducted by Barrera and colleagues at the Hospital for
Sick Children in Toronto, siblings of pediatric cancer patients participated in an 8 week group
program. The group met weekly for 2 hours in a hospital and was led by two therapists. Each
session focused on a different goal or theme, such as group rules, medical information,
family, siblings' feelings, relationships, schools, hope for the future, and finally closing
thoughts. The sessions were structured beginning with a fun activity or review of last weeks
theme, and then continuing with the main theme of that week. Parents were kept updated on
the status and progress of their child in the class. Group interaction improved each week,
with the participants becoming more involved in discussion and the activities. At the end of
the study, the participants were evaluated through self-reports and satisfaction questionnaires.
Levels of anxiety and depression were significantly lower after the program's completion.
Self-reports demonstrated a reduction in fear of cancer and improved thoughts and feelings

toward cancer. Participants said that they felt that the program was useful in reducing their
worries. They felt like they learned more about pediatric cancer, could express their feelings
better, and communicate with their parents and others more effectively. This study shows that
programs can be effective at minimizing the negative effects cancer can have on patients'
siblings (Barrera et a!., 2002).
Pediatric cancer can have a dramatic effect on the entire family. The need for
intervention programs for each member of the immediate family is imperative for the
positive adjustment of all members. Coping strategies, social support, and therapy programs
are all effective ways for families to manage this difficult time. It is important to remember
that each family member is facing different stressors from the diagnosis and treatment of the
cancer. A unique plan should be established for each person. Family-centered care should
become a vital part in the management of pediatric cancer.
Reasons for Research
As a senior in college, I have been exposed to a number of significant learning experiences
that will impact me in my future endeavors. However, nothing in my undergraduate work
will have such an impact as the research that I conducted under the direction of Dr. Lori
Hensley, and the subsequent research that I have done to write this Honors Thesis. Why is
this so important to me? After graduation, I plan on pursuing a career as a Physician
Assistant. Although I do not know what speciality I will choose, I will be working with
patients on a daily basis. This research has given me a glimpse into an emotional subject that
many children and parents must deal with. With this background in cancer research and in
psychological research, I will be able to relate to my patients more effectively and provide or

refer them to the resources they need to get through a difficult time. I can relate this research
to other illnesses other than pediatric cancer. Any health issue that changes the patient or
families' lives will have the potential to cause stress, anxiety, depression, and a number of
other psychological issues. I will apply what I have learned through this research and will
continue to learn in Physician Assistant school how to care for my patients fully and to the
best of my ability.
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